School of Public Health University College Cork Cork Ireland.
INFANT Research Centre University College Cork Ireland.
J Am Heart Assoc. 2021 May 4;10(9):e018494. doi: 10.1161/JAHA.120.018494. Epub 2021 Apr 17.
Background Maternal chronic hypertension is associated with adverse pregnancy outcomes. Previous studies examined the association between either chronic hypertension or antihypertensive treatment and adverse pregnancy outcomes. We aimed to synthesize the evidence on the effect of chronic hypertension/antihypertensive treatment on adverse pregnancy outcomes. Methods and Results Medline/PubMed, EMBASE, and Web of Science were searched; we included observational studies and assessed the effect of race/ethnicity, where possible, following a registered protocol (CRD42019120088). Random-effects meta-analyses were used. A total of 81 studies were identified on chronic hypertension, and a total of 16 studies were identified on antihypertensive treatment. Chronic hypertension was associated with higher odds of preeclampsia (adjusted odd ratio [aOR], 5.43; 95% CI, 3.85-7.65); cesarean section (aOR, 1.87; 95% CI, 1.6-2.16); maternal mortality (aOR, 4.80; 95% CI, 3.04-7.58); preterm birth (aOR, 2.23; 95% CI, 1.96-2.53); stillbirth (aOR, 2.32; 95% CI, 2.22-2.42); and small for gestational age (SGA) (aOR, 1.96; 95% CI, 1.6-2.40). Subgroup analyses indicated that maternal race/ethnicity does not influence the observed associations. Women with chronic hypertension on antihypertensive treatment (versus untreated) had higher odds of SGA (aOR, 1.86; 95% CI, 1.38-2.50). Conclusions Chronic hypertension is associated with adverse pregnancy outcomes, and these associations appear to be independent of maternal race/ethnicity. In women with chronic hypertension, those on treatment had a higher risk of SGA, although the number of studies was limited. This could result from a direct effect of the treatment or because severe hypertension during pregnancy is a risk factor for SGA and women with severe hypertension are more likely to be treated. The effect of antihypertensive treatment on SGA needs to be further tested with large randomized controlled trials.
母体慢性高血压与不良妊娠结局有关。先前的研究检查了慢性高血压或降压治疗与不良妊娠结局之间的关联。我们旨在综合有关慢性高血压/降压治疗对不良妊娠结局影响的证据。
我们检索了 Medline/PubMed、EMBASE 和 Web of Science;我们纳入了观察性研究,并在可能的情况下按照注册方案(CRD42019120088)评估了种族/民族的影响。使用随机效应荟萃分析。共确定了 81 项关于慢性高血压的研究,以及 16 项关于降压治疗的研究。慢性高血压与子痫前期(调整后的优势比 [aOR],5.43;95%置信区间,3.85-7.65)、剖宫产(aOR,1.87;95%置信区间,1.6-2.16)、产妇死亡率(aOR,4.80;95%置信区间,3.04-7.58)、早产(aOR,2.23;95%置信区间,1.96-2.53)、死产(aOR,2.32;95%置信区间,2.22-2.42)和胎儿生长受限(SGA)(aOR,1.96;95%置信区间,1.6-2.40)的风险更高相关。亚组分析表明,产妇种族/民族并不能影响观察到的相关性。与未接受治疗的慢性高血压女性相比,接受降压治疗的女性发生 SGA 的风险更高(aOR,1.86;95%置信区间,1.38-2.50)。
慢性高血压与不良妊娠结局相关,这些关联似乎与产妇种族/民族无关。在患有慢性高血压的女性中,接受治疗的女性 SGA 的风险更高,尽管研究数量有限。这可能是由于治疗的直接作用,也可能是因为怀孕期间严重的高血压是 SGA 的一个危险因素,而且患有严重高血压的女性更有可能接受治疗。需要进一步进行大型随机对照试验来检验降压治疗对 SGA 的影响。